CLPT
Clearpoint Neuro Inc
13.80$
+0.7%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 53.5% | 43.3% | 46.0% | 39.3% | 33.1% | 35.1% | 28.9% | 31.8% | 34.2% | 43.2% | 39.1% | 38.6% | |
| 46.5% | 56.7% | 54.0% | 60.7% | 66.9% | 64.9% | 71.1% | 68.2% | 65.8% | 56.8% | 60.9% | 61.4% | |
| 91.5% | 42.6% | 45.7% | 38.1% | 31.4% | 25.1% | 36.5% | 56.9% | 53.0% | 48.9% | 39.5% | 37.6% | |
| 223.0% | 182.2% | 72.9% | 54.8% | 58.8% | 38.4% | 41.1% | 49.1% | 46.8% | 49.1% | 38.2% | 44.6% | |
| 314.5% | 224.8% | 184.3% | 146.6% | 138.3% | 105.8% | 119.6% | 150.3% | 145.3% | 150.5% | 123.8% | 126.7% | |
| -147.6% | -195.3% | -130.3% | -85.9% | -71.4% | -41.0% | -48.5% | -82.1% | -79.5% | -93.7% | -62.9% | -65.4% | |
| 28.3% | 27.5% | 18.4% | 11.8% | 13.3% | 8.5% | 11.3% | 6.0% | 0.4% | 1.6% | 1.7% | 6.5% | |
| -125.5% | -183.9% | -140.4% | -97.1% | -83.8% | -49.4% | -52.9% | -88.4% | -80.0% | -92.2% | -60.3% | -68.9% | |
| 67.5% | 32.5% | 22.2% | 12.1% | 0.9% | 8.6% | 18.1% | 5.6% | 0.5% | 5.4% | -60.3% | 0.1% | |
| -125.5% | -183.9% | -140.4% | -97.1% | -83.8% | -49.4% | -52.9% | -88.4% | -80.0% | -92.2% | -60.3% | -69.1% | |
| -86.8% | -151.8% | -119.2% | -83.7% | -69.0% | -38.6% | -37.3% | -78.2% | -75.8% | -86.1% | -54.2% | -56.4% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.